Based on our observations in MPM tumours and cell lines, we next evaluated the occurrence of high CDKN2A and CCNE1 expressions and their relationship with RB1 defects using publicly available RNA‐seq data from cohorts of the Bueno et al. The gene discussed is CDKN2A; the disease is neoplasm.